Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Validation of Different Risk Assessment Strategies in Normotensive Pulmonary Embolism

Condition:   Pulmonary Embolism.
Intervention:  
Sponsor:   Azienda Ospedaliera Cosenza
Not yet recruiting - verified July 2016

Retrospective Study of Acute Chest Pain in Extremely Critical Condition for More Than Ten Years

Conditions:   Acute Myocardial Infarction;   Pulmonary Embolism;   Aortic Dissection
Intervention:  
Sponsor:   Qilu Hospital
Recruiting - verified July 2016

Age Related D-dimer Evaluation for the Exclusion of a Left Atrium Thrombus in Patients With Atrial Fibrillation (ADDIT-AF)

Condition:   Atrial Fibrillation
Intervention:   Procedure: Blood sampling
Sponsor:   Brugmann University Hospital
Not yet recruiting - verified July 2016

INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis

Condition:   Superficial Vein Thrombosis
Interventions:   Drug: any drug;   Procedure: any procedure/surgery;   Other: Any non-pharmacological treatment of SVT
Sponsor:   GWT-TUD GmbH
Recruiting - verified July 2016

Deep Venous Thrombosis After Hepatobiliopancreatic Surgery

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Hepatectomy;   Pancreatectomy
Intervention:  
Sponsor:   Technische Universität Dresden
Recruiting - verified July 2016

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Condition:   Venous Thromboembolism
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2016

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Condition:   Transcatheter Aortic Valve Replacement
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified July 2016

Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico

Conditions:   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:   Drug: Apixaban
Sponsor:   Bristol-Myers Squibb
Recruiting - verified July 2016

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Placebo
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified July 2016

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Epoetin alfa
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified July 2016

Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population

Condition:   Pulmonary Embolism
Intervention:  
Sponsor:   Chinese Pulmonary Vascular Disease Research Group
Recruiting - verified July 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin
Sponsor:   Bayer
Recruiting - verified July 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsor:   Bayer
Recruiting - verified July 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsor:   Bayer
Recruiting - verified July 2016

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Recruiting - verified May 2016

Identify Clinical Conditions That Increase Circulating DNA Levels

Conditions:   Pregnancy;   Pulmonary Embolism;   Myocardial Infarction;   Autoimmune Disease
Intervention:   Other: One time blood draw to look at patient's DNA
Sponsor:   University of Florida
Active, not recruiting - verified July 2016

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2016

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2016

Optimal Duration of Anticoagulation in Deep Venous Thrombosis

Conditions:   Deep Vein Thrombosis of Lower Limb;   Lower Extremity Deep Venous Thrombosis Recurrent
Intervention:   Drug: Sodium warfarin
Sponsor:   University of Padova
Completed - verified July 2016

Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)

Condition:   Ankylosing Spondylitis
Intervention:  
Sponsor:   Merck Sharp & Dohme Corp.
Active, not recruiting - verified July 2016

Erythropoietin in Traumatic Brain Injury (EPO-TBI)

Condition:   Traumatic Brain Injury
Interventions:   Drug: Epoetin Alfa;   Drug: Sodium Chloride 0.9%
Sponsors:   Australian and New Zealand Intensive Care Research Centre;   National Health and Medical Research Council, Australia;   Australian and New Zealand Intensive Care Society Clinical Trials Group;   Monash University
Completed - verified July 2016

Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome

Condition:   Antiphospholipid Syndrome
Intervention:  
Sponsor:   Duke University
Recruiting - verified July 2016

Identifying Low-Risk Patients With Pulmonary Embolism

Conditions:   Pulmonary Embolism;   Lung Diseases
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified January 2008

Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II)

Conditions:   Lung Diseases;   Pulmonary Embolism;   Venous Thromboembolism
Intervention:   Device: Tomography, X-ray Computed
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified January 2008